Inventor · disambiguated record
Balamurali K. Ambati
Also filed as: AMBATI BALAMURALI · AMBATI BALAMURALI K · AMBATI BALAMURALI KRISHNA
12 granted patents·20 pending applications·88 citations·filing 2006–2024
90Inventor score
Files withUNIV UTAH RES FOUND15AMBATI BALAMURALI K5AMBATI BALAMURALI3UNIV OREGON2AMBATI BALAMURALI KRISHNA1
Top patents by PatentIndex Score
32 records- 0190US8663194B2Intraocular drug delivery device and associated methodsAMBATI BALAMURALI K·Filed 2010·Granted Mar 4, 2014·25 cites·9 claims
- 0289US9447166B2Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptorsAMBATI BALAMURALI·Filed 2014·Granted Sep 20, 2016·14 cites·5 claims
- 0388US9534222B2Morpholinos, morpholino upregulating, and associated methodsAMBATI BALAMURALI K·Filed 2012·Granted Jan 3, 2017·14 cites·6 claims
- 0487US10588855B2Intraocular drug delivery device and associated methodsUNIV UTAH RES FOUND·Filed 2016·Granted Mar 17, 2020·4 cites·24 claims
- 0587US9198981B2Modulation of angiogenesisAMBATI BALAMURALI KRISHNA·Filed 2006·Granted Dec 1, 2015·15 cites·13 claims
- 0683US9877973B2Intraocular drug delivery device and associated methodsUNIV UTAH RES FOUND·Filed 2017·Granted Jan 30, 2018·2 cites·23 claims
- 0781US11065275B2Cross-linking agents and associated methodsUNIV UTAH RES FOUND·Filed 2016·Granted Jul 20, 2021·3 cites·13 claims
- 0881US8211864B2Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptorsAMBATI BALAMURALI·Filed 2006·Granted Jul 3, 2012·5 cites·9 claims
- 0978US11524032B2Treatment of myopic progressionUNIV UTAH RES FOUND·Filed 2019·Granted Dec 13, 2022·3 cites·19 claims
- 1077US10064819B2Intraocular drug delivery device and associated methodsAMBATI BALAMURALI K·Filed 2012·Granted Sep 4, 2018·2 cites·13 claims
- 1168US2024325378A1Pergolide treatment of ocular chemical injuryUNIV OREGON·Filed 2024·Application pending·0 cites
- 1262US2023145406A1Divalent metal-containing biomaterials and methods of useUNIV OREGON·Filed 2022·Application pending·0 cites
- 1361US2021322470A1Cross-linking agents and associated methodsUNIV UTAH RES FOUND·Filed 2021·Application pending·0 cites
- 1458US2013130980A1Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by IntraceptorsAMBATI BALAMURALI·Filed 2012·Application pending·0 cites
- 1557US9095404B2Intraocular drug delivery device and associated methodsAMBATI BALAMURALI K·Filed 2011·Granted Aug 4, 2015·1 cites·22 claims
- 1656US9506069B2Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularizationUNIV UTAH RES FOUND·Filed 2013·Granted Nov 29, 2016·0 cites·16 claims
- 1755US2018250311A1Intraocular drug delivery device and associated methodsUNIV UTAH RES FOUND·Filed 2018·Application pending·0 cites
- 1854US2018141995A1Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by IntraceptorsMEDICAL COLLEGE OF GEORGIA RES INSTITUTE·Filed 2016·Application pending·0 cites
- 1951US2024122974A1Treatment of myopiaUNIV UTAH RES FOUND·Filed 2022·Application pending·0 cites
- 2050US2022401580A1Optidicer construct for age-related macular degenerationUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2150US2016263184A1Methods of controlling vascularity using raver2 as a mediator for expression of vegf receptor sfit1UNIV UTAH RES FOUND·Filed 2014·Application pending·0 cites
- 2249US2007255402A1Wound closure methodMOORE JACOB J·Filed 2007·Application pending·0 cites
- 2348US2017218375A1Morpholinos, morpholino upregulating, and associated methodsUNIV UTAH RES FOUND·Filed 2017·Application pending·0 cites
- 2448US2024091255A1Treatment of astigmatismIVEENA DELIVERY SYSTEMS INC·Filed 2022·Application pending·0 cites
- 2547US2017218363A1Morpholino-mediated increase in soluble flt-1 expression results in decreased ocular and tumor neovascularizationUNIV UTAH RES FOUND·Filed 2016·Application pending·0 cites
- 2644US2022031449A9Customized optical lens based on patient-specific measurement dataWAVEPRINT TECH·Filed 2019·Application pending·0 cites
- 2742US2015100046A1Intraocular drug delivery device and associated methodsAMBATI BALAMURALI K·Filed 2013·Application pending·0 cites
- 2841US2022288114A1Multi-agent ocular formulations and treatment methodsUNIV UTAH RES FOUND·Filed 2020·Application pending·0 cites
- 2939US2019008837A1Ophthalmic compositions and associated methodsUNIV UTAH RES FOUND·Filed 2017·Application pending·0 cites
- 3038US2016030502A1Eye Health SupplementSAUCEDO ADAM C·Filed 2015·Application pending·0 cites
- 3137US2017304367A1Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)UNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
- 3235US2016331588A1Schlemm's canal stent-sieveUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Balamurali K. Ambati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →